Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

NCT04218123 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Meniere Disease

Interventions

DRUG: Venlafaxine
DRUG: Placebo oral tablet

Sponsor

Medical University of South Carolina

Collaborators

[object Object]
[object Object]